QIAGEN and CENTOGENE to collaborate in bioinformatics for genetic diseases
Aiding the analysis of hereditary disorders by integrating genomic and clinical databases Hilden and Rostock, Germany, and Germantown, Maryland, October 09, 2017 –QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and CENTOGENE AG today announced a collaboration and co-marketing agreement to provide customers more complete Sample to Insight research and clinical testing solutions in rare genetic diseases.... Read more